G R O U P   S T A T S

  • 19 members
  • 15 members have PhDs
  • Backgrounds include: Organic and Inorganic Chemistry, Chemical Engineering, Material Science, Bioengineering, and Chemical Biology

Our CMT Group has expertise in virtually all areas of chemistry, chemical engineering, and materials science. All group members have advanced degrees from top universities including MIT, Harvard, and Stanford.

Client testimonial:
"The quality of our science is very high, and our inventors are really smart. The Wolf team understands our science, and that is critical.”

Our clients include top academic & research institutions such as Harvard Medical School, MIT, and Dana Farber Cancer Institute as well as growing companies in medical devices (DEKA), industrial filtration (Hollingsworth & Vose), and solid state lighting (Luminus Devices), to name a few. They call on us to protect their most valuable cutting edge technologies, such as new battery chemistries that deliver higher power, processes for forming biodegradable compositions, and light emitting device designs that enhance light emission. Not only do we have an in-depth understanding of these technologies, but we take the time to get to know our clients’ businesses so that we can partner with them to achieve their strategic goals.

Client testimonial:
"Wolf Greenfield attorneys really are able to put themselves in our shoes and understand our business. In addition to the hands-on prosecution and portfolio, they also provide more strategic advice regarding positioning portfolios, dealing with partners, and helping us get to a dominant position in our field so that we would be a beneficial partner to another entity.”

The group provides a full range of IP services including: patent preparation and prosecution, opinions and studies related to infringement and patentability, licensing, IP due diligence, interferences, oppositions, litigation, trademarks, and strategic counseling. In order to provide our clients with support on IP issues internationally, we also maintain close working relationships with associates around the world. Our global reach and expertise in all aspects of IP allow us to help clients look at the bigger picture and identify potential issues as well as opportunities to stay ahead of the game.

Client testimonial:
"We are very happy with Wolf Greenfield. They do an outstanding job for us. They stand out because they are always proactively reaching out and thinking about us.”
  • For a developer of a microchip-based implant for drug delivery applications, we performed a detailed study of the company’s portfolio and the surrounding patent landscape—identifying several opportunities where there was significant commercial potential and little competitor activity. Based on our findings, our client expanded a number of its research programs to capitalize on this “white space.”
  • We secured broad patent portfolio protection related to coffee extraction technology and liquid coffee extracts—a key asset facilitating the acquisition of our client by a multinational food company.
  • We developed and grew a start-up client’s patent portfolio through venture financing, exit, and growth after being acquired by a multinational pharmaceutical and diagnostics company. Through these stages, we managed our client’s patent portfolio, advised on filing strategies, and carried out patent prosecution, freedom to operate, and due diligence studies. We also assisted with our client’s interactions with investors, suppliers, partners, and potential acquirers, while carefully staying within their budget.
  • We manage IP for a company developing topical formulations, and oversaw the licensing of the IP to a major pharmaceutical company in a deal that was valued in the hundreds of millions of dollars.
  • We manage a complex portfolio of closely-related patent families in the microfluidics space on behalf of a leading research university. There are over 70 different patent families with six different licensees, and several new start-up companies planned for various portions of the portfolio.
  • On behalf of a water services company, we filed a third-party submission in the patent application of a competitor pursuing claims that would create potential freedom to operate issues for our client. The third-party submission led to a final rejection of the claims concerned, and to amendment of the claims by the applicant so as to eliminate the freedom to operate issues.
  • We drafted and prosecuted a patent on behalf of a provider of microcellular foam technology related to injection molding of polymeric material. The patent was asserted against a competitor in a case that settled favorably at an early stage.
  • On behalf of a developer and manufacturer of high-performance LEDs, we drafted and prosecuted a portfolio of patents in the display space that was sold to a technology licensing company.
  • On behalf of a client in the waste water treatment industry, we filed a patent application to provoke an interference challenging the inventorship and ownership of a patent application obtained by a customer directed to technology invented by our client. The interference led to a settlement in which the customer abandoned its patent application and requested advance judgment from the Patent Office, closing the path for our client’s patent application to issue as a patent.

Representative clients:

  • Afton Chemical Corporation - manufacturer of petroleum additives
  • Agency for Science, Technology and Research (A*STAR) - public sector agency in Singapore that develops innovative technologies
  • AgNovos Healthcare - manufacturer of bone graft and bone cement materials
  • Braemar Energy Ventures - venture capital firm focused on alternative and traditional energy markets
  • Cambridge Display Technology Limited - developer of polymer organic light emitting diode (P-OLED) display technology
  • CESI Chemical, Inc. - developer, manufacturer, and marketer of specialty chemicals used in oil and gas well cementing, stimulation, drilling, and production treatment (subsidiary of Flotek Industries, Inc.)
  • Davol Inc. - medical device company focused on soft tissue reconstruction, including products for hernia repair, specialized surgical procedures, fixation and biologic implants (subsidiary of C.R. Bard, Inc.)
  • DEKA Research & Development Corporation - research and development company founded by entrepreneur and inventor Dean Kamen
  • E Ink Corporation - developer of electronic paper displays (EPD), founded as a spin-off from the MIT Media Lab
  • FastCap Systems Corporation - company that develops and commercializes energy storage devices for hybrid and electric vehicles
  • FLIR Systems, Inc. - designer, manufacturer, and marketer of thermal imaging infrared cameras
  • Flotek Industries Inc. - global supplier of drilling and production products and services to the energy and mining industries
  • Fraunhofer Center for Sustainable Energy Systems (CSE) - nonprofit applied research and development laboratory commercializing clean energy technologies
  • Gradiant Corporation - water services company that offers solutions for oil and gas and water-critical industrial applications
  • Greene Lyon Group, Inc. - developer and licensor of technologies focused primarily on recycling precious metals from scrap materials and industrial by-products
  • Harvard University & Medical School - Harvard's Office of Technology Development is responsible for managing its intellectual property assets for the public good
  • Kadant Inc. - global leader in fiber processing; fluid handling; doctoring, cleaning, and filtration; and wood processing systems
  • Lumicell Inc. - developer and marketer of image-guided cancer surgery solutions
  • Luminus Devices, Inc. - LED manufacturer
  • Massachusetts Institute of Technology - MIT's Technology Licensing Office manages commercial investment in and licensing of inventions and discoveries from research at MIT and Lincoln Laboratory
  • Moderna Therapeutics - pharmaceutical company focused on messenger RNA (mRNA)
  • National Nonwovens - innovative nonwoven textile materials for a variety of applications, including medical and aerospace
  • Nufern - manufacturer of fiber optics and metalized pigtails serving the telecommunication, industrial, medical, and aerospace industries
  • OPKO Diagnostics, LLC - division of OPKO Health, Inc., a multinational pharmaceutical and diagnostic company
  • Quanterix Corporation - developer of tools in high definition diagnostics
  • Radiation Monitoring Devices, Inc. - research business unit of Dynasil Corporation of America focusing on security, medical and industrial applications
  • Seventh Sense Biosystems, Inc. - early stage, venture-backed company developing health monitoring products
  • Sion Power Corporation - developer of high-energy rechargeable battery technology
  • Sony Corporation - manufacturer of audio, home video game consoles, communications, and key device and information technology products
  • T+ink - develops and delivers “thinking ink” technology applications
  • Trexel, Inc. - provider of MuCell® microcellular foam technology for injection molding
  • Trelleborg AB - producer of engineered heat-sealable polyurethane coated fabrics and composites for manufacturers
  • Xcede Technologies - developer and manufacturer of innovative hemostatic and sealant products for surgical applications
  • Xtalic Corporation - producer of nanostructured metal alloys for connector, PCB, and emerging applications

Recent Articles:

In press
"Handbook of Clinical Nanomedicine: Law, Business, Regulation, Safety and Risk: Chapter 10" by Michael J. Pomianek
This volume examines nanomedical products’ entire "product life cycle" from the creation of nanomedical products to the final market introduction. It not only provides a comprehensive roadmap of basic and clinical research but also tackles critical topics such as intellectual property law. Read more

April 8, 2015
"Diagnostic patenting since Myriad: an update" by Patrick R. H. Waller and Daniel W. Young
Stakeholders shouldn’t conclude that nothing is patent eligible in the diagnostic space. Read more

March 2014
"
CRISPR/Cas-9: An Exciting Addition to Genomic Editing"
by Patricia Granahan and Chelsea A. Loughran
This article provides an in-depth review of (1) the science behind this new technology, (2) several of the research groups responsible for the promising applications for this technology, and (3) the related and evolving intellectual property (IP) landscape. Read more

February 2014
"
The New World of Diagnostic Testing Post-Myriad"
by Patrick R. H. Waller and Daniel W. Young
Claims to isolated DNA segments that exist in nature are not patent eligible, but claims to certain synthetic molecules relevant to genetic testing—as well as certain method-of-use patents—likely remain patent eligible. Read more

To view older publications, go to Publications

The Safe Harbor Under 271(e)(1): Is Post-Approval Activity "Routine"?


G R O U P   S T A T S

  • 19 members
  • 15 members have PhDs
  • Backgrounds include: Organic and Inorganic Chemistry, Chemical Engineering, Material Science, Bioengineering, and Chemical Biology

Our CMT Group has expertise in virtually all areas of chemistry, chemical engineering, and materials science. All group members have advanced degrees from top universities including MIT, Harvard, and Stanford.

Client testimonial:
"The quality of our science is very high, and our inventors are really smart. The Wolf team understands our science, and that is critical.”

Our clients include top academic & research institutions such as Harvard Medical School, MIT, and Dana Farber Cancer Institute as well as growing companies in medical devices (DEKA), industrial filtration (Hollingsworth & Vose), and solid state lighting (Luminus Devices), to name a few. They call on us to protect their most valuable cutting edge technologies, such as new battery chemistries that deliver higher power, processes for forming biodegradable compositions, and light emitting device designs that enhance light emission. Not only do we have an in-depth understanding of these technologies, but we take the time to get to know our clients’ businesses so that we can partner with them to achieve their strategic goals.

Client testimonial:
"Wolf Greenfield attorneys really are able to put themselves in our shoes and understand our business. In addition to the hands-on prosecution and portfolio, they also provide more strategic advice regarding positioning portfolios, dealing with partners, and helping us get to a dominant position in our field so that we would be a beneficial partner to another entity.”

The group provides a full range of IP services including: patent preparation and prosecution, opinions and studies related to infringement and patentability, licensing, IP due diligence, interferences, oppositions, litigation, trademarks, and strategic counseling. In order to provide our clients with support on IP issues internationally, we also maintain close working relationships with associates around the world. Our global reach and expertise in all aspects of IP allow us to help clients look at the bigger picture and identify potential issues as well as opportunities to stay ahead of the game.

Client testimonial:
"We are very happy with Wolf Greenfield. They do an outstanding job for us. They stand out because they are always proactively reaching out and thinking about us.”
  • For a developer of a microchip-based implant for drug delivery applications, we performed a detailed study of the company’s portfolio and the surrounding patent landscape—identifying several opportunities where there was significant commercial potential and little competitor activity. Based on our findings, our client expanded a number of its research programs to capitalize on this “white space.”
  • We secured broad patent portfolio protection related to coffee extraction technology and liquid coffee extracts—a key asset facilitating the acquisition of our client by a multinational food company.
  • We developed and grew a start-up client’s patent portfolio through venture financing, exit, and growth after being acquired by a multinational pharmaceutical and diagnostics company. Through these stages, we managed our client’s patent portfolio, advised on filing strategies, and carried out patent prosecution, freedom to operate, and due diligence studies. We also assisted with our client’s interactions with investors, suppliers, partners, and potential acquirers, while carefully staying within their budget.
  • We manage IP for a company developing topical formulations, and oversaw the licensing of the IP to a major pharmaceutical company in a deal that was valued in the hundreds of millions of dollars.
  • We manage a complex portfolio of closely-related patent families in the microfluidics space on behalf of a leading research university. There are over 70 different patent families with six different licensees, and several new start-up companies planned for various portions of the portfolio.
  • On behalf of a water services company, we filed a third-party submission in the patent application of a competitor pursuing claims that would create potential freedom to operate issues for our client. The third-party submission led to a final rejection of the claims concerned, and to amendment of the claims by the applicant so as to eliminate the freedom to operate issues.
  • We drafted and prosecuted a patent on behalf of a provider of microcellular foam technology related to injection molding of polymeric material. The patent was asserted against a competitor in a case that settled favorably at an early stage.
  • On behalf of a developer and manufacturer of high-performance LEDs, we drafted and prosecuted a portfolio of patents in the display space that was sold to a technology licensing company.
  • On behalf of a client in the waste water treatment industry, we filed a patent application to provoke an interference challenging the inventorship and ownership of a patent application obtained by a customer directed to technology invented by our client. The interference led to a settlement in which the customer abandoned its patent application and requested advance judgment from the Patent Office, closing the path for our client’s patent application to issue as a patent.

Representative clients:

  • Afton Chemical Corporation - manufacturer of petroleum additives
  • Agency for Science, Technology and Research (A*STAR) - public sector agency in Singapore that develops innovative technologies
  • AgNovos Healthcare - manufacturer of bone graft and bone cement materials
  • Braemar Energy Ventures - venture capital firm focused on alternative and traditional energy markets
  • Cambridge Display Technology Limited - developer of polymer organic light emitting diode (P-OLED) display technology
  • CESI Chemical, Inc. - developer, manufacturer, and marketer of specialty chemicals used in oil and gas well cementing, stimulation, drilling, and production treatment (subsidiary of Flotek Industries, Inc.)
  • Davol Inc. - medical device company focused on soft tissue reconstruction, including products for hernia repair, specialized surgical procedures, fixation and biologic implants (subsidiary of C.R. Bard, Inc.)
  • DEKA Research & Development Corporation - research and development company founded by entrepreneur and inventor Dean Kamen
  • E Ink Corporation - developer of electronic paper displays (EPD), founded as a spin-off from the MIT Media Lab
  • FastCap Systems Corporation - company that develops and commercializes energy storage devices for hybrid and electric vehicles
  • FLIR Systems, Inc. - designer, manufacturer, and marketer of thermal imaging infrared cameras
  • Flotek Industries Inc. - global supplier of drilling and production products and services to the energy and mining industries
  • Fraunhofer Center for Sustainable Energy Systems (CSE) - nonprofit applied research and development laboratory commercializing clean energy technologies
  • Gradiant Corporation - water services company that offers solutions for oil and gas and water-critical industrial applications
  • Greene Lyon Group, Inc. - developer and licensor of technologies focused primarily on recycling precious metals from scrap materials and industrial by-products
  • Harvard University & Medical School - Harvard's Office of Technology Development is responsible for managing its intellectual property assets for the public good
  • Kadant Inc. - global leader in fiber processing; fluid handling; doctoring, cleaning, and filtration; and wood processing systems
  • Lumicell Inc. - developer and marketer of image-guided cancer surgery solutions
  • Luminus Devices, Inc. - LED manufacturer
  • Massachusetts Institute of Technology - MIT's Technology Licensing Office manages commercial investment in and licensing of inventions and discoveries from research at MIT and Lincoln Laboratory
  • Moderna Therapeutics - pharmaceutical company focused on messenger RNA (mRNA)
  • National Nonwovens - innovative nonwoven textile materials for a variety of applications, including medical and aerospace
  • Nufern - manufacturer of fiber optics and metalized pigtails serving the telecommunication, industrial, medical, and aerospace industries
  • OPKO Diagnostics, LLC - division of OPKO Health, Inc., a multinational pharmaceutical and diagnostic company
  • Quanterix Corporation - developer of tools in high definition diagnostics
  • Radiation Monitoring Devices, Inc. - research business unit of Dynasil Corporation of America focusing on security, medical and industrial applications
  • Seventh Sense Biosystems, Inc. - early stage, venture-backed company developing health monitoring products
  • Sion Power Corporation - developer of high-energy rechargeable battery technology
  • Sony Corporation - manufacturer of audio, home video game consoles, communications, and key device and information technology products
  • T+ink - develops and delivers “thinking ink” technology applications
  • Trexel, Inc. - provider of MuCell® microcellular foam technology for injection molding
  • Trelleborg AB - producer of engineered heat-sealable polyurethane coated fabrics and composites for manufacturers
  • Xcede Technologies - developer and manufacturer of innovative hemostatic and sealant products for surgical applications
  • Xtalic Corporation - producer of nanostructured metal alloys for connector, PCB, and emerging applications

Recent Articles:

In press
"Handbook of Clinical Nanomedicine: Law, Business, Regulation, Safety and Risk: Chapter 10" by Michael J. Pomianek
This volume examines nanomedical products’ entire "product life cycle" from the creation of nanomedical products to the final market introduction. It not only provides a comprehensive roadmap of basic and clinical research but also tackles critical topics such as intellectual property law. Read more

April 8, 2015
"Diagnostic patenting since Myriad: an update" by Patrick R. H. Waller and Daniel W. Young
Stakeholders shouldn’t conclude that nothing is patent eligible in the diagnostic space. Read more

March 2014
"
CRISPR/Cas-9: An Exciting Addition to Genomic Editing"
by Patricia Granahan and Chelsea A. Loughran
This article provides an in-depth review of (1) the science behind this new technology, (2) several of the research groups responsible for the promising applications for this technology, and (3) the related and evolving intellectual property (IP) landscape. Read more

February 2014
"
The New World of Diagnostic Testing Post-Myriad"
by Patrick R. H. Waller and Daniel W. Young
Claims to isolated DNA segments that exist in nature are not patent eligible, but claims to certain synthetic molecules relevant to genetic testing—as well as certain method-of-use patents—likely remain patent eligible. Read more

To view older publications, go to Publications

The Safe Harbor Under 271(e)(1): Is Post-Approval Activity "Routine"?